Another study from the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) cohort also reported a significant increase in anti-MAA IgG antibody among early RA patients (within 1 year of diagnosis), especially among those who are ACPA positive (33). Here, PRTN3 is linked to rheumatoid arthritis.